Investor Relations Home

Printer Friendly Version Print Page  |E-mail this page E-mail Page  |E-mail Alerts E-mail Alerts  |View contacts IR Contacts

Corporate Profile

About Bio-Reference Laboratories, Inc.
BioReference is the third largest full service clinical diagnostic laboratory in the U.S. providing testing and related services to physician offices, clinics, hospitals, long term care facilities, employers, governmental units and correctional institutions. We offer a comprehensive test list focusing on molecular diagnostics, anatomical pathology, genetics, and women’s health. Moreover, through its GeneDx subsidiary, BioReference has an international presence in more than 50 countries around the world.

Read More »

Recent NewsMore »
DateTitle 
04/14/15BioReference Laboratories Partners With Organizations Accelerating Medical InnovationPrinter Friendly Version
03/05/15Bio-Reference Laboratories, Inc. Reports Over 15% Increase in Revenue; Net Income Up Over 100%, Year Over YearPrinter Friendly Version
02/26/15BioReference Laboratories, Inc. Announces Earnings Date for First Quarter Fiscal Year 2015Printer Friendly Version
Stock Quote
BRLI (common stock)
ExchangeNASDAQ (US Dollar)
Price$33.35
Change (%) - 0.41 (1.21%)
Volume226,998
Data as of 05/22/15 4:00 p.m. ET
Refresh quote
Receive E-mail AlertsE-mail Alert Icon
Sign up to receive e-mail alerts whenever Bio-Reference Laboratories, Inc. posts new information to the site. Just enter your e-mail address and click Submit.

Data provided by Nasdaq. Minimum 15 minutes delayed.